Despite progress on several issues, the talks stalled on several longstanding disagreements, including Canadian dairy market access, Japanese barriers to auto and rice imports, and U.S. demands for strong intellectual property protections for a new generation of pharmaceuticals.
The countries in the deal, which also include Mexico, Australia, New Zealand, Malaysia and Vietnam, account for 40 percent of global economic output. Read More: HERE
